ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 712,47
0,04%
Dow Jones
43 487,83
0,78%
DAX
20 898,44
0,00%
Brent Oil
79,735
-0,60%
Bitcoin
107 620,66
4,37%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) Actualités

NVRO

Nevro (NVRO)

Nevro Corp
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:NVRO
DateHeureSourceTitreSymboleSociété
14/01/202518h29Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
13/01/202514h30PR Newswire (US)Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue ResultsNYSE:NVRONevro Corp
06/01/202522h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
17/12/202422h30PR Newswire (US)Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08NYSE:NVRONevro Corp
04/12/202422h27Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNYSE:NVRONevro Corp
18/11/202414h30PR Newswire (US)New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral ApproachesNYSE:NVRONevro Corp
14/11/202423h31Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NYSE:NVRONevro Corp
14/11/202423h18Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:NVRONevro Corp
12/11/202413h00PR Newswire (US)Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion GloballyNYSE:NVRONevro Corp
11/11/202422h05PR Newswire (US)Nevro Reports Third-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
29/10/202421h30PR Newswire (US)New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation TherapyNYSE:NVRONevro Corp
10/10/202422h45PR Newswire (US)Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024NYSE:NVRONevro Corp
24/09/202414h00PR Newswire (US)Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord StimulationNYSE:NVRONevro Corp
28/08/202422h15PR Newswire (US)Nevro to Present at Wells Fargo 2024 Healthcare ConferenceNYSE:NVRONevro Corp
06/08/202422h48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NVRONevro Corp
06/08/202422h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVRONevro Corp
06/08/202422h05PR Newswire (US)Nevro Reports Second-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
09/07/202422h15PR Newswire (US)Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024NYSE:NVRONevro Corp
11/06/202422h15PR Newswire (US)Nevro to Present at Truist Securities MedTech ConferenceNYSE:NVRONevro Corp
17/05/202422h40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
09/05/202422h05PR Newswire (US)Nevro to Present at BofA Securities 2024 Healthcare ConferenceNYSE:NVRONevro Corp
07/05/202422h05PR Newswire (US)Nevro Reports First-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
17/04/202414h30PR Newswire (US)Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024NYSE:NVRONevro Corp
28/02/202422h10PR Newswire (US)Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewNYSE:NVRONevro Corp
21/02/202422h06PR Newswire (US)Nevro Enters Into Cooperation Agreement With Engaged CapitalNYSE:NVRONevro Corp
21/02/202422h05PR Newswire (US)Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:NVRONevro Corp
14/02/202421h47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
01/02/202422h30PR Newswire (US)Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyNYSE:NVRONevro Corp
29/01/202422h30PR Newswire (US)Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024NYSE:NVRONevro Corp
18/01/202422h15PR Newswire (US)Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic NeuropathyNYSE:NVRONevro Corp
 Showing the most relevant articles for your search:NYSE:NVRO

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
EU
RI
Pernod Ricard
COIN
BTCUSD
Bitcoin
EU
VIV
Vivendi
NASDAQ
GOOGL
Alphabet
EU
EN
Bouygues
NYSE
NKE
Nike
EU
CS
Axa
NASDAQ
NVDA
NVIDIA
EU
VK
Vallourec
NASDAQ
MSFT
Microsoft
EU
HO
Thales
EU
ACA
Credit Agricole
EU
BNP
BNP Paribas
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés